Delivery Order SPE2DB20D2001-SPE2DB24FM54V
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,521.52, is for the supply of Imitrex 6 mg/0.5 ml cartridges to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $4,786.23 and a completion date of May 17, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,564,171,029 units of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract has a firm fixed price of $12,332.63 and a period of performance through April 5, 2024. There is no set-aside designation associated with this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.18 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml cartridges on January 26, 2026, with completion anticipated by January 27, 2026. The contract was awarded on a firm fixed-price basis without set-aside designation, reflecting open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMITREX 6 mg/0.5 mL cartridges on February 2, 2026, with a contract ceiling value of $3,034.01. The delivery order, which is not set-aside and competitively awarded with firm fixed pricing, is scheduled for completion by February 3, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- This federal contract award is a delivery order valued at $3,187.05, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a prescription medication used for the treatment of migraines. The contract has a firm fixed price pricing type and an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a firm fixed price of $12,124.38 and a completion date of March 7, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,222.25 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a prescription medication used for migraine...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Imitrex 6 mg/0.5 ml cartridges, a prescription migraine medication. The total ceiling value of the contract is $13,412.57, and it has an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM54VDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,036.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp to provide 4,564,220,914 units of Imitrex 6 mg/0.5 ml cartridges. This contract has an ultimate completion date of April 10, 2024 and was not set aside for any specific business category. AmerisourceBergen, a for-profit pharmaceutical distributor, is a key vendor for federal healthcare programs, particularly supporting military and veterans' medical needs through major Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice valued at up to $999,999,999 and $750,000 respectively. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies across various therapeutic areas to serve the healthcare requirements of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 4/9/24 |